cancer-therapy

Google DeepMind and Yale released C2S-Scale, a 27B parameter foundation model built on Gemma for single-cell analysis that discovered a promising drug combination (silmitasertib and interferon) to enhance immune visibility of "cold" tumors, with predictions validated through experimental confirmation.